MTHFR and breast cancer: A meta-analysis by Li et al., involving 57 case-control studies, suggested that C677T polymorphisms in the MTHFR gene may contribute to breast cancer development, while the A1298C polymorphism was not associated with disease risk (Li et al., 2014).